Hints and tips:
Related Special Reports
...The sector is seeing growth and innovation even from established players such as pharmaceuticals giant Almac, which grew out of Northern Ireland’s first £1 billion company and is now building new manufacturing...
...Ireland’s economy has officially entered recession after contracting by 1.9 per cent in the third quarter, pushed lower by a drop in pharmaceutical exports....
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
...In Ireland, it has declined to compensate people given experimental vaccines as children by its predecessor companies in the country’s notorious mother and baby homes....
...In response to these concerns, Pfizer initiated a significant cost-cutting programme, worth at least $4bn....
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...Goodbody estimated that part of the recent decline in Ireland’s industrial output reflected “the fall-off in pharmaceutical exports after the Covid boom”....
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
...Ireland’s Mother and Baby Homes Commission of Investigation in 2021 detailed the “systemic vaccine trials”....
...Shares in consumer pharmaceutical group Haleon rose 8 per cent on Thursday after it forecast stronger than anticipated sales for 2024 and announced share buybacks worth £500mn....
...Big airlines and the Irish prime minister have warned that maintaining the cap could hit an economy where multinationals such as Microsoft, Apple, Google and Pfizer pay billions of euros in corporation tax...
...Partners have included Pfizer and Eli Lilly and it generated Rmb16.1bn ($2.2bn) in revenues last year from the 20 largest names and earned Rmb26bn — about two-thirds of its revenues — from the US, which...
...Pfizer, a supplier of methotrexate to 40 countries, is increasing production at sites in Australia, but this requires investing in more staff, specialist equipment and manufacturing capacity, measures that...
...Ireland is now a manufacturing centre for some of the world’s top-selling drugs, including Merck’s cancer therapy Keytruda and Pfizer’s Covid-19 vaccine....
...Share moves to note on the New York Stock Exchange include Vertex Pharmaceuticals, Apple and Pfizer: Apple gained 1.7 per cent to a record high close of $197.96 a share....
...Strong vaccine sales powered British pharmaceutical company GSK to higher than expected earnings in 2023, as the company’s new RSV jab gained “blockbuster” status just over six months after its US launch...
...Since it was spun off from pharmaceutical giant GSK in 2022, the London-listed company has taken steps to streamline its business with a restructuring programme and job cuts, together with the disposal of...
...Pharmaceutical companies must replenish their drugs pipeline before exclusivity rights on top-selling products expire....
...The world’s top global tech and pharmaceutical companies have set up in the country and are major contributors to state coffers via their taxes....
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
...There have been large investments in vaccine delivery systems in recent years, such as the mRNA technology used for the BioNTech/Pfizer and Moderna Covid-19 vaccines....
...GLP-1s now underpin a weight loss drug, Wegovy, developed by pharmaceutical group Novo Nordisk....
...Last week, Pfizer slashed its 2024 revenue outlook and increased its cost-cutting programme by $500mn....
...Uğur Şahin, the company’s chief executive, will update on ten oncology trials in the year ahead at a pharmaceutical industry conference in San Francisco later on Tuesday....
...The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US....
International Edition